UK markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.4500+0.0800 (+2.37%)
At close: 04:00PM EDT
3.4500 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
15,431
111,026
7,194
Operating expenses
Research development
64,076
62,282
59,487
50,432
44,277
Selling general and administrative
10,707
10,879
11,086
9,421
7,564
Total operating expenses
80,589
79,010
76,691
66,490
56,744
Operating income or loss
-80,589
-79,010
-61,260
44,536
-49,550
Interest expense
709
581
184
1,894
298
Total other income/expenses net
-290
113
-555
2,529
-1,194
Income before tax
-75,103
-72,993
-61,921
45,442
-50,951
Income tax expense
7
3
0
0
0
Income from continuing operations
-75,110
-72,996
-61,921
45,442
-50,951
Net income
-75,110
-72,996
-61,921
45,442
-50,951
Net income available to common shareholders
-75,110
-72,996
-61,921
45,442
-50,951
Basic EPS
-
-0.97
-0.86
0.64
-0.82
Diluted EPS
-
-0.97
-0.86
0.64
-0.82
Basic average shares
-
74,952
71,900
70,604
61,838
Diluted average shares
-
74,952
71,900
71,103
61,838
EBITDA
-
-70,006
-59,770
49,030
-49,692